PRKAA1 and osteosarcoma: To assess whether AMPK provided protection against cell death induced by cordycepin, we utilized double-knockout (AMPK DKO) human osteosarcoma (U2OS) cells in which both the α1 and the α2 catalytic subunit isoforms had been knocked out using CRISPR.